mi2-factory GmbH, a high-tech start-up in the field of semiconductor equipment, today announces the closing of a EUR 15 million Series A financing and the commitment of a government grant from the ICPEI ME/CT program of up to EUR 23 million.
The Belgian company Ion Beam Applications S.A. (IBA), world market leader in particle accelerator technology, and the public investment company Wallonie Entreprendre International (WE International), together with beteiligungsmanagement thüringen gmbh (bm|t) and a family office, are investing a total of EUR 15 million in mi2-factory GmbH. The Federal Ministry of Economics and Climate Protection (BMWK) and the Free State of Thuringia are also providing a total of EUR 23 million in public funds from the IPCEI ME/CT program.
The investment and funding will make it possible to bring the patented, proprietary EFIITRON technology, which has been tested on a laboratory scale, to industrial maturity and to demonstrate its first industrial use. Chip manufacturers will use EFIITRON in the future to reduce chip costs, increase reliability and realize new component and wafer architectures. Chip manufacturers will benefit from the unprecedented precision and flexibility of deep doping in SiC. This enables a cost reduction of up to 30% for silicon carbide (SiC) chips. EFIITRON is targeting the strategic market of silicon carbide power electronics for e‑mobility, renewable energies, AI data centers, traction and industrial drives. Renowned studies expect a market volume of > $6 billion in 2027 with a CAGR of 30–40%. mi2-factory has set itself the goal of processing more than 30% of all SiC wafers with EFIITRON systems in the long term.
The strategic investor IBA contributes its extensive experience and leading know-how in the field of compact particle accelerator technologies to the development and design of EFIITRON and thus plays a decisive role in the industrialization of EFIITRON technology as a European high-tech process technology.
About IBA
IBA (Ion Beam Applications S.A.) is a world leader in particle accelerator technology. The company is the leading provider of equipment and services in the field of proton therapy, which is considered the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmacy and dosimetry. Based in Louvain-la-Neuve, Belgium, the company employs around 2,000 people worldwide. IBA is a certified B Corporation (B Corp), which meets the highest standards for verified social and environmental standards. IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
For more information: www.iba-worldwide.com
About Wallonie Entreprendre
WE International (Wallonie Entreprendre International S.A.) is the international arm of the Walloon public investment company Wallonie Entreprendre S.A. For more than 20 years, WE International has been dedicated to financing Walloon companies with projects abroad that bring significant economic benefits to Wallonia.
For more information: https://www.wallonie-entreprendre.be/en/expertises/international/
About bm|t
Erfurt-based beteiligungsmanagement thüringen (bm|t) — a subsidiary of Thüringer Aufbaubank — is the first port of call for equity investments in Thuringia. bm‑t currently manages twelve investment funds with a total volume of EUR 445 million. bm‑t invests in innovative and fast-growing companies from all sectors and in all phases of the corporate life cycle.
For more information: www.bm‑t.de
About mi2-Factory
mi2-factory GmbH was founded in Jena in 2016 as a spin-off of the Ernst Abbe University of Applied Sciences in Jena. mi2-factory GmbH develops and markets its innovative EFIITRON wafer processing technology for SiC chip production. Chip manufacturers use EFIITRON to reduce chip costs, increase reliability and realize new component and wafer architectures. Customers of mi2-factory include well-known chip manufacturers from Europe, Japan and the USA. mi2-factory has applied for 16 patent families, of which a total of 30 patents have been granted in Germany, the USA, Europe, Japan and China.
For more information: www.mi2-factory.com